Finnrick - Ensuring a Safer and More Transparent Supply Chain

Free peptides test: now with paid endotoxins contamination option

Huayi Biotechnology

Huayi Biotechnology

Tirzepatide

Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Huayi Biotechnology between 1 Sep 2025 and 7 Jan 2026. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).

Finnrick Rating™
Tentative Rating
Huayi Biotechnology
Tirzepatide
Tested 4 Samples
Last test 7 Jan 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Huayi Biotechnology

Samples are tested in commercial labs

Tests Count

4

Scores

AVG7.4MIN5.0MAX9.9

Last

7 Jan 2026

First

1 Sep 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
7 Jan 2026View6.75mg5.3mg+6.0%99.50%(no batch ID)No Label / Silver Crimp / Black CapLab GPublic
18 Sep 2025View5.015mg11.6mg-22.7%99.93%(no batch ID)No Label / Silver Crimp / Clear Pink Cap Lab EPublic
4 Sep 2025View8.010mg9.99mg-0.1%99.91%(no batch ID)No Label / Silver Crimp / Clear Green Cap Lab EPublic
1 Sep 2025View9.920mg21.02mg+5.1%99.86%Jul 17, 2025No Label / Silver Crimp / Violet CapLab FPublic